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Over the past decade, there has been a surge in optical
coherence tomography (OCT) usage in coronary diagnostic and
interventional procedures. High-resolution images from OCT
provide a detailed analysis of coronary stent strut apposition,
neointimal formation, thrombus attachment, as well as plaque
characterization [1,2]. Tissue characterization of atherosclerotic
coronary plaques with OCT was ﬁrst carried out by comparing the
OCT images to the matched histology using autopsy specimens.
Each of the three major plaque types is characterized by a speciﬁc
set of features: ﬁbrous plaques appear as homogeneous, signal-rich
regions; lipid plaques as signal-poor regions with diffuse borders;
and calciﬁed plaques as signal-poor legions with sharp borders [1].
Frequency domain (FD)-OCT systems have allowed clinicians
to rapidly obtain high-resolution intravascular images over long
arterial segments without the balloon occlusion unlike the
formerly used time-domain OCT. This improvement in hardware
has facilitated the clinical application of OCT in the management of
coronary artery disease [2]. The foremost limitation of OCT is
decreased tissue penetrance at the expense of its high resolution
and need for intraluminal blood clearance. Recently, clinicians
have started using OCT for peripheral artery disease appreciating
the high-quality images free from blood artifacts [3]. While the
coronary vessels can be rendered free of blood by a 12 to 15-cc
bolus injection of contrast injected at a rate of 2–4 mL/s [2], larger
size peripheral artery requires higher injection rates and volume of
ﬂush medium for adequate blood clearance compared to coronary
imaging. We have to take care in dealing the patients with renal
insufﬁciency. A case report from Stefano et al. demonstrated that
OCT can provide the dimensions of a dissection (depth and length)
as well as precise delineation of the most proximal edge of the
dissection, information imperative to implementing proper
treatment with repeat balloon angioplasty, and/or stenting afterDOI of original article: http://dx.doi.org/10.1016/j.jccase.2015.03.009
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OCT-based tissue/plaque characterization has yet to be established
in peripheral artery disease through direct comparison of OCT
images and histopathology. Morphological information by OCT
before and after intervention in peripheral artery disease as an
adjunctive endovascular imaging would help us to make treatment
decisions whether additional stent placement is needed.
Renovascular hypertension from ﬁbromuscular dysplasia and
OCT assessments
Fibromuscular dysplasia (FMD) is an idiopathic, segmental,
nonatherosclerotic disease of the musculature of arterial walls,
leading to the narrowing of small and medium-sized arteries (most
commonly renal arteries) and causing renovascular hypertension.
FMD is the second most frequent cause of renal artery stenosis
(RAS), which accounts for up to 10% of cases of renovascular
hypertension, with the remainder caused mainly by atherosclerosis.
FMD patients tend to be female and younger, with lower occurrence
of atherosclerosis in other vessels. Histologically, medial dysplasia is
the most common type of FMD which occurs as areas with a thinned
medial wall layer alternating with thickened ﬁbromuscular ridges
containing collagen, and vessel wall ischemia appears to be of
relevance for the development of FMD [4].
Besides physical examinations, renal artery ultrasound, capto-
pril renography, magnetic resonance angiography, and computed
tomographic angiography, intra-arterial digital subtraction angi-
ography is the gold standard for exclusion or conﬁrmation of RAS
caused by FMD. The FMD lesion is typically truncal or distal and
often shows ‘strings of beads’ appearance. Mizutani et al. report a
case of OCT usage for visualization of intimal ﬁbroplasia and
medial hyperplasia that was indicative of FMD in young female
hypertensive patient [5]. OCT showed that, especially in media,
the inside was homogeneous and was of low intensity, which
suggested FMD.
Treatment options are medical, endovascular [percutaneous
transluminal renal angioplasty (PTRA)], and surgical. Invasive
treatment should be considered when hypertension cannot be
controlled with antihypertensive drugs as with the patient in this
report and in patients with impaired renal function. PTRA has
become the treatment of choice and normally yields good results,
especially in unifocal disease and young patients. After PTRA,
pressure gradients are normally completely abolished, and there is
no indication for stent placement in most cases [6]. Indications for
stenting of FMD lesions include severe procedural complications reserved.
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repeated angioplasty [7]. Since OCT can clearly visualize achieved
lumen area, vessel dissection, and thrombus formation after
balloon angioplasty [2], it may help us to optimize PTRA for FMD. In
a systematic review of FMD treatment [7], when ‘cure’ following
revascularization for RAS due to FMD was deﬁned as blood
pressure less than 140/90 mmHg without treatment, cure rate was
reported in only 36% of the procedures. It was also reported that
the blood pressure outcome was strongly inﬂuenced by patient
age. Further study is warranted to assess early and long-term
outcome following OCT-guided optimization of PTRA for RAS.
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